Filing Summary
Business Context and Reporting Period
This Form 6-K was filed by Tremor International Ltd. for the month of July 2022 and dated July 11, 2022. The filing reports company announcements issued on July 5, 6, and 7, 2022 regarding transactions under the company’s share buyback program.
The request metadata identifies Nexxen International Ltd.; however, the filing itself identifies the registrant as Tremor International Ltd. and does not reference Nexxen.
Financial and Capital Markets Metrics
- No revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics are provided.
- The filing does not state the number of shares repurchased, purchase prices, aggregate consideration, or remaining buyback authorization in the supplied text.
- The filing incorporates the reported information by reference into the company’s Form S-8 registration statement No. 333-258731, to the extent not superseded by later filings.
Material Changes Versus the Prior Comparable Period
No comparative-period financial information or operating performance changes are discussed. The only reported activity is the issuance of three share buyback transaction announcements.
Guidance, Outlook, Risks, and Unusual Items
- No guidance, outlook, management commentary, risk update, contingency, or unusual operating item is disclosed in the filing text.
- The share repurchases may affect shares outstanding and capital allocation, but the financial magnitude and resulting share count are not provided.
Investor Verification Items
- Verify the correct registrant name, because the supplied metadata names Nexxen International Ltd., while the filing names Tremor International Ltd.
- Review Exhibits 99.1, 99.2, and 99.3 for the dates, number of shares purchased, transaction prices, and aggregate consideration.
- Confirm the cumulative effect of the transactions on shares outstanding and the remaining authorization under the buyback program.
- Check subsequent filings for additional repurchases or information superseding this Form 6-K.